Issue 3/2003
Content (16 Articles)
Progesterone Receptors A and B Differentially Affect the Growth of Estrogen-Dependent Human Breast Tumor Xenografts
Carol A. Sartorius, Tianjie Shen, Kathryn B. Horwitz
Inositol Hexaphosphate (IP6) Enhances the Anti-Proliferative Effects of Adriamycin and Tamoxifen in Breast Cancer
Kwanchanit Tantivejkul, Ivana Vucenik, Julie Eiseman, AbulKalam M. Shamsuddin
Growth and Fatty Acid Metabolism of Human Breast Cancer (MCF-7) Xenografts in Nude Rats: Impact of Constant Light-Induced Nocturnal Melatonin Suppression
David E. Blask, Robert T. Dauchy, Leonard A. Sauer, Jean A. Krause, George C. Brainard
JNK/SAPK Mediates Doxorubicin-Induced Differentiation and Apoptosis in MCF-7 Breast Cancer Cells
Jayoung Kim, Michael R. Freeman
Ornithine Decarboxylase (ODC) as a Prognostic Factor in Operable Breast Cancer
Richard R. Love, Stephanie H. Astrow, Alan M. Cheeks, Thomas C. Havighurst
Effect of Ligands of Nuclear Hormone Receptors on Sodium/Iodide Symporter Expression and Activity in Breast Cancer Cells
Sakae Tanosaki, Takayuki Ikezoe, Anthony Heaney, Jonathan W. Said, Kazuo Dan, Makoto Akashi, H. Phillip Koeffler
Incidence of Anaemia in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Ursula Denison, Jose Baumann, Christian Peters-Engl, Hellmut Samonigg, Peter Krippl, Alois Lang, Andreas Obermair, Helga Wagner, Paul Sevelda
HER2 Codon 655 Polymorphism and Risk of Breast Cancer in African Americans and Whites
Robert Millikan, Allison Eaton, Kendra Worley, Lorna Biscocho, Elizabeth Hodgson, Wen-Yi Huang, Joseph Geradts, Mary Iacocca, David Cowan, Kathleen Conway, Lynn Dressler
Long Term Inhibition by Estradiol or Progesterone of Melatonin Secretion After Administration of a Mammary Carcinogen, the Dimethyl Benz(a)anthracene, in Sprague-Dawley Female Rat; Inhibitory Effect of Melatonin on Mammary Carcinogenesis
Marianne Beau Yon De Jonage-Canonico, Véronique Lenoir, Antoine Martin, Robert Scholler, Bernard Kerdelhué
Progesterone Receptor Expression in Medroxyprogesterone Acetate-Induced Murine Mammary Carcinomas and Response to Endocrine Treatment
Luisa A. Helguero, Marcelo Viegas, Aroumougame Asaithamby, Gopalan Shyamala, Claudia Lanari, Alfredo A. Molinolo
Use of the Peroxisome Proliferator-Activated Receptor (PPAR) γ Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study
Harold J. Burstein, George D. Demetri, Elisabetta Mueller, Pasha Sarraf, Bruce M. Spiegelman, Eric P. Winer
Role of CRE-Binding Protein (CREB) in Aromatase Expression in Breast Adipose
Mariam Sofi, Morag J. Young, Theodora Papamakarios, Evan R. Simpson, Colin D. Clyne
Polymorphisms in the Estrogen Receptor Beta Gene and Risk of Breast Cancer: No Association
Asta Försti, Chunyan Zhao, Elisabeth Israelsson, Karin Dahlman-Wright, Jan-Åke Gustafsson, Kari Hemminki